These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20434921)

  • 21. Bone regeneration in cranial defects previously treated with radiation.
    Nussenbaum B; Rutherford RB; Krebsbach PH
    Laryngoscope; 2005 Jul; 115(7):1170-7. PubMed ID: 15995502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
    Liu HW; Chen CH; Tsai CL; Hsiue GH
    Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects.
    Zhang Y; Song J; Shi B; Wang Y; Chen X; Huang C; Yang X; Xu D; Cheng X; Chen X
    Biomaterials; 2007 Nov; 28(31):4635-42. PubMed ID: 17664001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naturally derived materials-based cell and drug delivery systems in skin regeneration.
    Huang S; Fu X
    J Control Release; 2010 Mar; 142(2):149-59. PubMed ID: 19850093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of osteoinduction on bone regeneration in distraction: results of a pilot study.
    Kroczek A; Park J; Birkholz T; Neukam FW; Wiltfang J; Kessler P
    J Craniomaxillofac Surg; 2010 Jul; 38(5):334-44. PubMed ID: 19910206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral vectors for gene delivery in tissue engineering.
    Zhang X; Godbey WT
    Adv Drug Deliv Rev; 2006 Jul; 58(4):515-34. PubMed ID: 16762441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4).
    Huang YC; Simmons C; Kaigler D; Rice KG; Mooney DJ
    Gene Ther; 2005 Mar; 12(5):418-26. PubMed ID: 15647766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue engineering by modulated gene delivery.
    Yamamoto M; Tabata Y
    Adv Drug Deliv Rev; 2006 Jul; 58(4):535-54. PubMed ID: 16762442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors.
    Chen Y; Luk KD; Cheung KM; Xu R; Lin MC; Lu WW; Leong JC; Kung HF
    Gene Ther; 2003 Aug; 10(16):1345-53. PubMed ID: 12883531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.
    Park J; Ries J; Gelse K; Kloss F; von der Mark K; Wiltfang J; Neukam FW; Schneider H
    Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery).
    Bessa PC; Casal M; Reis RL
    J Tissue Eng Regen Med; 2008; 2(2-3):81-96. PubMed ID: 18383454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large-scale bicortical skull bone regeneration using ex vivo replication-defective adenoviral-mediated bone morphogenetic protein-2 gene-transferred bone marrow stromal cells and composite biomaterials.
    Chang SC; Lin TM; Chung HY; Chen PK; Lin FH; Lou J; Jeng LB
    Neurosurgery; 2009 Dec; 65(6 Suppl):75-81; discussion 81-3. PubMed ID: 19935005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
    Han D; Liu W; Ao Q; Wang G
    Med Hypotheses; 2008 Sep; 71(3):374-8. PubMed ID: 18565684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of endogenous regenerative technology for in situ regenerative medicine.
    Anitua E; Sánchez M; Orive G
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):741-52. PubMed ID: 20102730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-viral gene therapy for bone tissue engineering.
    Wegman F; Oner FC; Dhert WJ; Alblas J
    Biotechnol Genet Eng Rev; 2013; 29():206-20. PubMed ID: 24568281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects.
    Lutz R; Park J; Felszeghy E; Wiltfang J; Nkenke E; Schlegel KA
    Clin Oral Implants Res; 2008 Jun; 19(6):590-9. PubMed ID: 18422983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth factors and bone regeneration: how much bone can we expect?
    Nauth A; Ristevski B; Li R; Schemitsch EH
    Injury; 2011 Jun; 42(6):574-9. PubMed ID: 21489530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oro-maxillofacial bone tissue engineering combining biomaterials, stem cells, and gene therapy].
    Myon L; Ferri J; Chai F; Blanchemain N; Raoul G
    Rev Stomatol Chir Maxillofac; 2011 Sep; 112(4):201-11. PubMed ID: 21798570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A medical device for prefabrication of large bone grafts in modern medicine.
    Laflamme C; Rouabhia M
    Med Hypotheses; 2011 Apr; 76(4):489-91. PubMed ID: 21183285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonviral gene transfer strategies to promote bone regeneration.
    Im GI
    J Biomed Mater Res A; 2013 Oct; 101(10):3009-18. PubMed ID: 23554051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.